NeuBase Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q3 2010 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
NeuBase Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q3 2010 to Q3 2023.
  • NeuBase Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2023 was 3.73M shares, a 88.7% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 3.73M -29.3M -88.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.88M -30.4M -94.2% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 33.8M +1.55M +4.81% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 1.66M -31.1M -94.9% Dec 31, 2022 10-Q 2023-11-09
Q3 2022 33M +287K +0.88% Sep 30, 2022 10-QT 2023-06-05
Q2 2022 32.3M -458K -1.4% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 32.3M +9.08M +39.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 32.8M +9.59M +41.4% Dec 31, 2021 10-Q 2022-02-11
Q3 2021 32.7M +9.57M +41.3% Sep 30, 2021 10-K 2022-12-21
Q2 2021 32.7M +9.6M +41.5% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 23.2M +6.1M +35.7% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 23.2M +6.1M +35.7% Dec 31, 2020 10-Q 2021-02-11
Q3 2020 23.2M +6.08M +35.6% Sep 30, 2020 10-K 2021-12-23
Q2 2020 23.1M +20.3M +717% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 17.1M +14.3M +504% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 17.1M +14.2M +504% Dec 31, 2019 10-Q 2020-03-26
Q3 2019 17.1M +11.4M +198% Sep 30, 2019 10-K 2020-12-23
Q2 2019 2.83M -53.6M -95% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 2.83M -53.6M -95% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 2.83M -53.6M -95% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 5.73M -50.5M -89.8% Sep 30, 2018 10-K 2020-01-10
Q2 2018 56.5M +255K +0.45% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 56.5M +20.5M +57% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 56.4M +20.5M +56.9% Dec 31, 2017 10-Q 2018-02-14
Q3 2017 56.2M +24.1M +75.2% Sep 30, 2017 10-K 2019-01-03
Q2 2017 56.2M +24.7M +78.4% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 36M +4.46M +14.2% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 36M +5.01M +16.2% Dec 31, 2016 10-Q 2017-02-14
Q3 2016 32.1M +1.75M +5.75% Sep 30, 2016 10-K 2017-12-15
Q2 2016 31.5M +1.17M +3.87% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 31.5M +1.54M +5.14% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 31M +5.69M +22.5% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 30.3M +5.08M +20.1% Sep 30, 2015 10-K 2016-12-22
Q2 2015 30.3M +5.47M +22% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 30M +8.16M +37.4% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 25.3M +5.3M +26.5% Dec 31, 2014 10-Q/A 2015-02-10
Q3 2014 25.3M +5.51M +27.9% Sep 30, 2014 10-K 2015-12-14
Q2 2014 24.9M +5.18M +26.3% Jun 30, 2014 10-Q 2014-08-18
Q1 2014 21.8M -27.9M -56.1% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 20M -27.7M -58.1% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 19.7M +3.99M +25.3% Sep 30, 2013 10-K 2014-12-22
Q2 2013 19.7M Jun 30, 2013 10-Q 2013-08-13
Q1 2013 49.7M +8M +19.2% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 47.7M +6.15M +14.8% Dec 31, 2012 10-Q 2013-02-19
Q3 2012 15.8M -23.9M -60.3% Sep 30, 2012 10-K 2013-12-27
Q1 2012 41.7M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 41.5M Dec 31, 2011 10-Q/A 2012-02-14
Q3 2011 39.7M 0 0% Sep 30, 2011 10-K 2013-01-09
Q2 2011 39.7M Jun 30, 2011 10-Q 2011-08-15
Q3 2010 39.7M Sep 30, 2010 10-K/A 2012-01-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.